 Connection
Robert Ryu to Predictive Value of Tests
This is a "connection" page, showing publications Robert Ryu has written about Predictive Value of Tests.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.312 |
|
|
|
-
Sutter CM, Ryu RK. Percutaneous Management of Malignant Biliary Obstruction. Tech Vasc Interv Radiol. 2015 Dec; 18(4):218-26.
Score: 0.080
-
Oppenheimer JD, Kasuganti D, Nayar R, Chrisman HB, Lewandowski RJ, Nemcek AA, Ryu RK. How to interpret thyroid biopsy results: a three-year retrospective interventional radiology experience. Cardiovasc Intervent Radiol. 2010 Aug; 33(4):800-5.
Score: 0.054
-
Gordon AC, Gates VL, White SB, Harris KR, Procissi D, Zhang Z, Li W, Samaan D, Nicolai JR, Mouli SK, Sato KT, Ryu RK, Omary RA, Salem R, Lewandowski RJ, Larson AC. Correlation and Agreement of Yttrium-90 Positron Emission Tomography/Computed Tomography with Ex Vivo Radioembolization Microsphere Deposition in the Rabbit VX2 Liver Tumor Model. J Vasc Interv Radiol. 2021 01; 32(1):23-32.e1.
Score: 0.029
-
Ryu R. Friday afternoon pulmonary arteriography. AJR Am J Roentgenol. 1999 Mar; 172(3):836.
Score: 0.026
-
Ryu R, Timperman P, Caruso V, Coldwell D. Re: Friday afternoon pulmonary arteriography (FAPA): are Fridays good for your health? Cardiovasc Intervent Radiol. 1997 Sep-Oct; 20(5):404.
Score: 0.023
-
Salem R, Vouche M, Baker T, Herrero JI, Caicedo JC, Fryer J, Hickey R, Habib A, Abecassis M, Koller F, Vogelzang R, Desai K, Thornburg B, Hohlastos E, Resnick S, Lewandowski RJ, Sato K, Ryu RK, Ganger D, Kulik L. Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis. Transplantation. 2015 Nov; 99(11):2347-55.
Score: 0.021
-
Wang D, Gaba RC, Jin B, Lewandowski RJ, Riaz A, Memon K, Ryu RK, Sato KT, Kulik LM, Mulcahy MF, Larson AC, Salem R, Omary RA. Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma. Radiology. 2014 Aug; 272(2):587-97.
Score: 0.018
-
Memon K, Kulik LM, Lewandowski RJ, Wang E, Wang J, Ryu RK, Hickey R, Vouche M, Baker T, Ganger D, Gates VL, Habib A, Mulcahy MF, Salem R. Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization. J Vasc Interv Radiol. 2014 Jul; 25(7):1056-66.
Score: 0.018
-
Memon K, Kulik L, Lewandowski RJ, Wang E, Ryu RK, Riaz A, Nikolaidis P, Miller FH, Yaghmai V, Baker T, Abecassis M, Benson AB, Mulcahy MF, Omary RA, Salem R. Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis. J Hepatol. 2012 May; 56(5):1112-1120.
Score: 0.016
-
Riaz A, Lewandowski RJ, Kulik L, Ryu RK, Mulcahy MF, Baker T, Gates V, Nayar R, Wang E, Miller FH, Sato KT, Omary RA, Abecassis M, Salem R. Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization. Cardiovasc Intervent Radiol. 2010 Dec; 33(6):1143-52.
Score: 0.014
-
Lewandowski RJ, Wang D, Gehl J, Atassi B, Ryu RK, Sato K, Nemcek AA, Miller FH, Mulcahy MF, Kulik L, Larson AC, Salem R, Omary RA. A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring. J Vasc Interv Radiol. 2007 Oct; 18(10):1249-57.
Score: 0.012
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|